HomeTOP STORIESNovartis to acquire Tourmaline Bio in $1.4B all-cash deal Novartis to acquire Tourmaline Bio in $1.4B all-cash deal By rogerjudd September 9, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleYext Non-GAAP EPS of $0.13 in-line, revenue of $113.1M in-lineNext articleASML to invest €1.3 billion in Mistral AI, marking Europe’s largest AI deal – report latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
